Prenatal Sirolimus Treatment for Rhabdomyomas in Tuberous Sclerosis.

Ebrahimi-Fakhari, Daniel; Stires, Gabrielle; Hahn, Eunice; Krueger, Darcy; Franz, David Neal

Ebrahimi-Fakhari, Daniel; Stires, Gabrielle; Hahn, Eunice; Krueger, Darcy; Franz, David Neal.

Afiliação

Ebrahimi-Fakhari D; Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of General Pediatrics, University Children's Hospital Muenster, Muenster, Germany. Electronic address: daniel.ebrahimi-fakhari@ukmuenster.de.
Stires G; Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Hahn E; The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Krueger D; Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Franz DN; Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: david.franz@cchmc.org.

Pediatr Neurol ; 125: 26-31, 2021 12.

Article em En | MEDLINE | ID: mdl-34624607

Assuntos

Antibióticos Antineoplásicos/farmacologia; Doenças Fetais/tratamento farmacológico; Rabdomioma/tratamento farmacológico; Sirolimo/farmacologia; Esclerose Tuberosa/tratamento farmacológico; Antibióticos Antineoplásicos/administração & dosagem; Feminino; Humanos; Gravidez; Sirolimo/administração & dosagem

Palavras-chave

Cardiac tumor; Fetal; Maternal; Rapamycin; Sirolimus; Transplacental; Tuberous sclerosis; mTOR inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomioma / Esclerose Tuberosa / Sirolimo / Doenças Fetais / Antibióticos Antineoplásicos Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google